Company news: Bristol-Myers Squibb, GSK, Bayer
The FDA sets review dates for Eliquis and FF/Vilanterol VI while also greenlighting Bayer's colorectal cancer drug.
Your Email Address: *
Recipient(s) Email Address: *
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
Your message:
The e-mail address(es) that you supply to use this service will only be used to send the requested article.